Robbins R J, Tuttle R M, Sonenberg M, Shaha A, Sharaf R, Robbins H, Fleisher M, Larson S M
Department of Medicine, Memorial Hospital for Cancer and Allied Diseases, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Thyroid. 2001 Sep;11(9):865-9. doi: 10.1089/105072501316973127.
Radioiodine ablation (RA) of normal thyroid remnants after thyroidectomy for differentiated thyroid carcinoma improves the sensitivity of subsequent radioiodine scans and serum thyroglobulin measurements for detection of residual thyroid carcinoma. Local cancer recurrences are also lower after RA. One standard preparation for RA involves rendering the patient hypothyroid in order to stimulate endogenous thyrotropin (TSH) secretion and sodium iodide symporter (NIS) activity. An alternative approach is to prescribe thyroxine after thyroidectomy and to stimulate NIS with exogenous recombinant human thyrotropin (rhTSH). This latter approach was used in 10 patients at our medical center. Complete resolution of all visible 131I thyroid bed uptake was achieved in all when follow-up scans were performed 5 to 13 months later. This approach has the potential to successfully ablate thyroid remnants without the need to induce hypothyroidism.
对于分化型甲状腺癌患者,甲状腺切除术后对正常甲状腺残余组织进行放射性碘消融(RA)可提高后续放射性碘扫描和血清甲状腺球蛋白测量对残留甲状腺癌检测的敏感性。RA后局部癌症复发率也较低。RA的一种标准准备方案是使患者处于甲状腺功能减退状态,以刺激内源性促甲状腺激素(TSH)分泌和钠碘同向转运体(NIS)活性。另一种方法是在甲状腺切除术后给予甲状腺素,并使用外源性重组人促甲状腺激素(rhTSH)刺激NIS。我们医疗中心的10例患者采用了后一种方法。5至13个月后进行随访扫描时,所有患者可见的131I甲状腺床摄取均完全消失。这种方法有可能在无需诱发甲状腺功能减退的情况下成功消融甲状腺残余组织。